2025-00099Notice

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Published Date: 1/7/2025

Notice

Summary

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on January 30-31, 2025, to review secret contract proposals for vaccine adjuvant development. This affects small businesses competing for government research funding and keeps sensitive info private. The meeting helps decide who gets money to boost vaccine innovation.

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Closed SBIR review for vaccine adjuvants

If you are a small business that submitted an SBIR contract proposal under Solicitation PHS 2025-1 (NIH/NIAID 142) for Adjuvant Development for Vaccines, your proposal will be reviewed and evaluated in a closed meeting on January 30–31, 2025, from 9:00 a.m. to 6:00 p.m. This meeting helps decide which small businesses receive contract funding for vaccine adjuvant work.

Confidentiality protection for proposals

The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information in contract proposals. If you submitted a proposal, your trade secrets and personal information will be kept private during review.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Effective Date
1/7/2025
1/30/2025

Department and Agencies

Department
Independent Agency
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register